SCHEMBL14213818

SCHEMBL14213818

C=CCC(C[Si](OC)(OC)OC)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.38
ALDH1A1 P00352 4/20 0.35
KDM4E B2RXH2 4/20 0.35
MAPT P10636 4/20 0.35
ALOX15 P16050 3/20 0.35
HSD17B10 Q99714 3/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TRPA1 O75762 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
PKM P14618 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HPGD P15428 3/20 0.31
USP2 O75604 2/20 0.31
TP53 P04637 2/20 0.31
CYP3A4 P08684 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9003499 0.78 CYP2C19 (0.55) CYP2C19SMN1; SMN2ALDH1A1KDM4EMAPT
SCHEMBL3859970 0.77 CYP1A2 (0.33) SMN1; SMN2ALDH1A1KMT2AL3MBTL1CYP1A2
SCHEMBL485620 0.77 SMN1; SMN2 (0.33) SMN1; SMN2ALDH1A1MAPTKMT2AL3MBTL1
SCHEMBL2133730 0.74 CYP2C19 (0.48) CYP2C19SMN1; SMN2ALDH1A1KDM4EMAPT
SCHEMBL4901936 0.74 CYP2C19 (0.48) CYP2C19SMN1; SMN2ALDH1A1KDM4EMAPT
SCHEMBL18662217 0.74 HRH1 (0.41) CYP2C19MEN1KMT2ACYP1A2CYP2D6
SCHEMBL1610252 0.72 CYP2C19 (0.50) CYP2C19SMN1; SMN2ALDH1A1KDM4EMAPT
SCHEMBL15816497 0.72 CYP2C19 (0.37) CYP2C19SMN1; SMN2ALDH1A1KDM4EMAPT
SCHEMBL4354928 0.72 CYP2C19 (0.46) CYP2C19SMN1; SMN2ALDH1A1KDM4EMAPT
SCHEMBL252241 0.71 GABBR2 (0.50) CYP2C19SMN1; SMN2ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8729195-B2 Organosilicon compound, method for producing thereof, and curable silicone composition containing the same DOW CORNING TORAY CO., LTD. (JP) 2014-05-20 US disclosed
US-20120309921-A1 Organosilicon Compound, Method For Producing Thereof, And Curable Silicone Composition Containing The Same DOW CORNING TORAY CO., LTD. (JP) 2012-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309921-A1 Organosilicon Compound, Method For Producing Thereof, And Curable Silicone Composition Containing The Same SRM, ESD, THEM6 CYP2C19 2540/4885SMN1; SMN2 1116/4885ALDH1A1 1008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.